Increased Neovascularization in Mice Lacking Tissue Inhibitor of Metalloproteinases-3
Author(s) -
Quteba Ebrahem,
Jian Qi,
Masahiko Sugimoto,
Mariya Ali,
Jonathan E. Sears,
Alecia Cutler,
Rama Khokha,
Amit Vasanji,
Bela AnandApte
Publication year - 2011
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.10-5899
Subject(s) - angiogenesis , matrix metalloproteinase , choroidal neovascularization , corneal neovascularization , neovascularization , vascular endothelial growth factor , extracellular matrix , biology , tissue inhibitor of metalloproteinase , cancer research , macular degeneration , endocrinology , microbiology and biotechnology , pathology , medicine , ophthalmology , genetics , vegf receptors
Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a matrix-bound inhibitor of matrix metalloproteinases (MMPs). The authors have previously determined a novel function of TIMP-3 to inhibit vascular endothelial growth factor (VEGF)-mediated angiogenesis. Here, the authors examined the in vivo angiogenic phenotype of ocular vessels in mice deficient in TIMP-3.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom